Impact of TheraWorx Foam on Symptom Relief in Thumb Arthritis

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-12-21

Study Completion Date

2020-08-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Thumb carpometacarpal osteoarthritis (CMC OA) affects up to 33% of people over the age of 40, which leads to inflammation, pain, and weakness of the CMC joint. Treatment modalities are both conservative and surgical with surgical options including osteotomy, bone excision, ligament reconstruction, and various prosthetic implants. The conservative treatment options, however, are limited to NSAIDs and bracing or steroid injections.

Advances in topical therapies have the potential to deliver focused treatment to the CMC joint. Novel treatment of inflammation can potentially reduce inflammation and pain associated with progressing osteoarthritis. Theraworx Relief is an FDA registered foam that has theoretical impact on inflammation reduction in human subjects treated with the topical foam.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Effect of Theraworx Foam in Carpal Tunnel Syndrome

NCT04017390

Carpal Tunnel Syndrome

WITHDRAWN PHASE4

Efficacy of a Single Injection of CTM for Post-Operative CMC Arthritis

NCT06171529

Osteoarthritis Osteoarthritis Thumb Base Joint Carpometacarpal Osteoarthritis +1 more

ENROLLING_BY_INVITATION NA

Extracorporeal Shock Waves Therapy (ESWT) vs Exercise in Thumb Osteoarthritis

NCT06056765

Thumb Osteoarthritis Hand Injuries

COMPLETED NA

Rhizarthrosis Study

NCT04587570

Rhizarthrosis

COMPLETED NA

Proprioceptive Thumb Exercises Program in Patients With Carpometacarpal Joint Osteoarthritis

NCT04738201

Thumb Osteoarthritis

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This pilot study seeks to investigate potential benefit in the use of Theraworx Foam in patients diagnosed with thumb CMC OA. Patients presenting to the upper extremity orthopedic surgery clinic for thumb/hand/wrist pain will be diagnosed by a Board Certified Hand Surgeon as per standard protocols. Patients who are recommended to follow a conservative treatment modality and are interested in participating in this study will be randomized into treatment or control groups. Both groups will undergo symptom assessment, strength testing, and range of motion testing prior to starting the standard conservative treatment of bracing. The treatment group will use the TheraWorx topical foam and the compression wrap nightly for 2 weeks for at least 6 hours per night. Control group will use a compression wrap for the same time period. Both groups will return at 1 and 2 weeks for repeat strength and range of motion testing and symptom assessment.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Arthritis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Foam and Compression Wrap

Patients will use Theraworx foam and a compression wrap

Group Type EXPERIMENTAL

Theraworx

Intervention Type DRUG

Theraworx foam applied to skin and/or compression wrap

Placebo Foam and Compression Wrap

Patients will use placebo foam and a compression wrap

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DRUG

Placebo foam

Foam alone

Patients will use Theraworx foam without compression wrap

Group Type EXPERIMENTAL

Theraworx

Intervention Type DRUG

Theraworx foam applied to skin and/or compression wrap

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Theraworx

Theraworx foam applied to skin and/or compression wrap

Intervention Type DRUG

Placebo

Placebo foam

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Thumb CMC arthritis
2. greater than or equal to age 18
3. Interested in non-operative treatment of thumb arthritis

Exclusion Criteria

1. Recent corticosteroid injection into the thumb joint
2. Non-English speaking
3. skin lesions or rashes on the thumb
4. current use of topical anti-inflammatory medications
5. concomitant thumb/wrist diagnoses that would impact the results (as determined by the PI)
6. known allergy to magnesium

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No